NASDAQ: COCH
Envoy Medical Inc Stock Ownership - Who owns Envoy Medical?

Insider buying vs selling

Have Envoy Medical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mona Chetan PatelDirector2024-11-202,500$2.28
$5.70kBuy
Mona Chetan PatelDirector2024-09-114,000$3.33
$13.32kBuy
Mona Chetan PatelDirector2024-09-091,000$3.20
$3.20kBuy

1 of 1

COCH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COCH insiders and whales buy or sell their stock.

COCH Shareholders

What type of owners hold Envoy Medical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Glen A. Taylor48.25%10,290,049$17.39MInsider
Atlas Merchant Capital LLC4.22%900,000$1.52MInsider
Barclays PLC4.21%897,087$1.52MInsider
Atlas Merchant Capital LLC2.60%555,527$938.84kInstitution
Weiss Asset Management LP1.86%396,654$670.35kInstitution
Vanguard Group Inc1.85%394,961$667.48kInstitution
Brent T. Lucas1.05%224,261$379.00kInsider
Dsg Capital Advisors LLC0.77%163,642$276.55kInstitution
Geode Capital Management LLC0.41%87,721$148.25kInstitution
Susan Kantor0.37%77,887$131.63kInsider

1 of 3

COCH vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COCH9.04%58.48%Net Buying
ECOR6.40%93.60%Net BuyingNet Buying
MODD34.78%21.39%Net BuyingNet Buying
MDAI13.36%53.79%Net Buying
TELA54.03%45.97%Net SellingNet Selling

Envoy Medical Stock Ownership FAQ

Who owns Envoy Medical?

Envoy Medical (NASDAQ: COCH) is owned by 9.04% institutional shareholders, 58.48% Envoy Medical insiders, and 32.48% retail investors. Glen A. Taylor is the largest individual Envoy Medical shareholder, owning 10.29M shares representing 48.25% of the company. Glen A. Taylor's Envoy Medical shares are currently valued at $17.39M.

If you're new to stock investing, here's how to buy Envoy Medical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.